Here, we review the current knowledge about the genetic characteristics of U1 snRNA, SF3B1, and U2AF1 somatic mutations and the mechanism by which they influence splicing decision and, as a consequence, tumor development. This evidence concerns the gene U2AF1 and neoplasm.